Skip to main content

Table 6 Classification of interventions based on network meta-analysis on alleviating global symptoms at 4-week follow-up: domperidone as comparator

From: Chinese herbal medicine for functional dyspepsia: a network meta-analysis of prokinetic-controlled randomised trials

Classification of intervention

CHM formula

Risk difference (95% CI)

Surface under the cumulative ranking curve

Certainty of evidence+

Moderate beneficial effect#

Modified Zhi Zhu Decoction

0.28 (− 0.03, 0.75)

0.85

Low

Small beneficial effect†

Xiao Pi Tong Jiang Decoction

0.15 (− 0.11, 0.57)

0.64

Low

Xiao Pi Kuan Wei Decoction

0.13 (− 0.11, 0.50)

0.61

Low

Jian Pi Yi Qi Decoction

0.13 (− 0.11, 0.49)

0.60

Low

Shu Gan Jian Pi He Wei Decoction

0.12 (− 0.11, 0.49)

0.59

Low

Xiang Su Li Qi Decoction

0.13 (− 0.11, 0.52)

0.59

Low

He Wei Decoction

0.10 (− 0.07, 0.34)

0.57

Very low

Modified He Gan Decoction

0.11 (− 0.12, 0.46)

0.54

Low

Liu Wei An Xiao Capsule

0.09 (− 0.07, 0.34)

0.53

Very low

Xiao Pi Decoction

0.09 (− 0.13, 0.44)

0.49

Low

Trivial to no beneficial effect‡

He Wei Xiao Pi Decoction

0.07 (− 0.14, 0.38)

0.42

Very low

Tiao He Gan Pi Xing Qi Decoction

0.06 (− 0.14, 0.38)

0.41

Low

Fu An Decoction

0.06 (− 0.14, 0.38)

0.40

Low

Cai Zhu Jie Yu Decoction

0.06 (− 0.15, 0.36)

0.38

Low

Zhi Zhu Kuan Zhong Capsule

− 0.03 (− 0.19, 0.22)

0.16

Very low

  1. CHM Chinese herbal medicine, CI Confidence interval
  2. #Moderate beneficial effect: 0.31 > risk difference ≥ 0.20
  3. †Small beneficial effect: 0.20 > risk difference ≥ 0.08
  4. ‡Trivial to no beneficial effect: risk difference < 0.08
  5. +Quality of evidence ratings for comparisons in network meta-analysis on alleviating global symptoms at 4-week follow-up (domperidone as the comparator). Details refer to Additional file 1: Appendix 4